Company presentation and Q&A at BioStock Investor Meeting
14 Sep 2022Event
Company presentation and Q&A at BioStock Investor Meeting
Cereno Scientific’s CEO Sten R. Sörensen and Chief Medical Officer Björn Dahlöf presented the company and participated on a Q&A session at BioStock Investor Meeting on September 14, 2022.